Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-108009
Filing Date
2024-10-11
Accepted
2024-10-11 14:20:23
Documents
6
Period of Report
2024-10-11

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2424074d8_6k.htm 6-K 10709
2 EXHIBIT 99.1 tm2424074d8_ex99-1.htm EX-99.1 11832
3 EXHIBIT 99.2 tm2424074d8_ex99-2.htm EX-99.2 37366
4 GRAPHIC tm2424074d8_ex99-1img001.jpg GRAPHIC 5938
5 GRAPHIC tm2424074d8_ex99-1img002.jpg GRAPHIC 1469
6 GRAPHIC tm2424074d8_ex99-2img001.jpg GRAPHIC 7495
  Complete submission text file 0001104659-24-108009.txt   82010
Mailing Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5
Business Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5 289-910-0850
Cardiol Therapeutics Inc. (Filer) CIK: 0001702123 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40712 | Film No.: 241367244
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)